How much funding has IDOVEN raised?

IDOVEN has raised $14.9M in total funding, most recently a Series B round.

Where is IDOVEN headquartered?

IDOVEN is headquartered in Madrid, Spain.

What industry is IDOVEN in?

IDOVEN operates in Artificial Intelligence, Healthcare.

IDOVEN

Q: Who are IDOVEN's investors?

IDOVEN's investors include Northzone, Insight Partners, Accel, Wayra.

AI-powered detection and precision medicine for cardiology

Madrid, Spain · Founded 2018 · $14.9M raised

Artificial Intelligence

Healthcare

Headquarters: Madrid
Employees: 51–200
Founded: 2018
Business Model: B2B

Website: idoven.ai
Total Funding: $14.9M
Last Round: $12.9M Series BSep 2023
Rounds: 3

About

Idoven develops AI-powered cardiovascular diagnostic tools and precision medicine solutions. Their flagship Willem™ platform analyzes electrocardiograms (ECGs) using AI trained on 1.8 million manually annotated ECG hours to detect 22 cardiac patterns, receiving CE Mark Class IIa certification in 2024. Positioned as a 'Cardiology-as-a-Service' platform, Idoven partners with MedTech manufacturers, pharmaceutical companies (including AstraZeneca and Abbott), and clinical research organizations to deliver faster, more accurate cardiac diagnoses and better-targeted treatments. The company was founded at Spain's National Cardiovascular Research Centre (CNIC) in Madrid.

Summary

IDOVEN is an Artificial Intelligence company based in Madrid, Spain, founded in 2018. It has raised $14.9M in total across 3 rounds, most recently a $12.9M Series B round in Sep 2023. Investors include Northzone, Insight Partners and Accel.

LinkedIn X (Twitter)